Share Email Print
cover

Proceedings Paper • new

Correlation of ultrasound tomography to MRI and pathology for the detection of prostate cancer
Author(s): Reza Seifabadi; Alexis Cheng; Bilal Malik; Shun Kishimoto; James Wiskin; Jeeva Munasinghe; Ayele H. Negussie; Ivane Bakhutashvili; Murali C. Krishna; Peter Choyke; Peter Pinto; Arman Rahmim; Emad M. Boctor; Maria Merino; Mark Lenox; Baris Turkbey; Bradford J. Wood
Format Member Price Non-Member Price
PDF $14.40 $18.00
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Purpose: This study aims to investigate correlation of speed of sound (SoS) map with T2-weighted (T2w) MRI and pathology in an ex vivo human prostate tissue with cancer, as an early proof of concept towards cost effective augmented ultrasound diagnosis of prostate cancer. Method: A commercial breast full angle ultrasound tomography scanner was used to generate US tomography images. Prostate-specific Echolucent mold was fabricated to allow MRI and UST to be spatially correlated. Similarly, a 3D printed mold was developed to align the histology slices with the UST and MRI. The resulting slices of prostate tissue were H and E stained. A radiologist with 10 years of experience in using multi parametric MRI for prostate cancer diagnosis labeled and contoured the suspicious ROIs in both MRI and UST. For all tissue blocks (N=10 slices with 6 mm thickness), H and E slides were prepared and labeled by an expert pathologist. Results: The radiologist found two slices with prominent cancer in each modality (i.e. MR and UST) in the peripheral zone. These two pairs of slices correlated with each other and with slices #5 and #7 in pathology. The cancer ROIs were found at similar locations in all modalities, although MR and UST underestimated the size of lesions (Sørensen–Dice coefficients, with respect to pathology, for T2w and UST were 0.11 and 0.20 respectively for first ROI, and 0.33 and 0.27 for second ROI). The SoS was 1580.4±17.7 m/s and 1571.4±9.2 m/s for normal and cancer tissues in first ROI, and 1577.7±17.7 m/s and 1574.5±10.1 m/s for second ROI. Conclusions: SoS map can correlate with MRI and pathology findings in prostate cancer. Further ex vivo validation with fresh prostate tissue is warranted.

Paper Details

Date Published: 15 March 2019
PDF: 9 pages
Proc. SPIE 10955, Medical Imaging 2019: Ultrasonic Imaging and Tomography, 109550C (15 March 2019); doi: 10.1117/12.2512001
Show Author Affiliations
Reza Seifabadi, National Institutes of Health (United States)
Alexis Cheng, National Institutes of Health (United States)
Bilal Malik, QT Ultrasound LLC (United States)
Shun Kishimoto, National Institutes of Health (United States)
James Wiskin, QT Ultrasound LLC (United States)
Jeeva Munasinghe, National Institutes of Health (United States)
Ayele H. Negussie, National Institutes of Health (United States)
Ivane Bakhutashvili, National Institutes of Health (United States)
Murali C. Krishna, National Institutes of Health (United States)
Peter Choyke, National Institutes of Health (United States)
Peter Pinto, National Institutes of Health (United States)
Arman Rahmim, Johns Hopkins Univ. (United States)
Univ. of British Columbia (Canada)
Emad M. Boctor, Johns Hopkins Univ. (United States)
Maria Merino, National Institutes of Health (United States)
Mark Lenox, QT Ultrasound LLC (United States)
Baris Turkbey, National Institutes of Health (United States)
Bradford J. Wood, National Institutes of Health (United States)


Published in SPIE Proceedings Vol. 10955:
Medical Imaging 2019: Ultrasonic Imaging and Tomography
Brett C. Byram; Nicole V. Ruiter, Editor(s)

© SPIE. Terms of Use
Back to Top